Skip to content

KMTS KMTS EV / sales

EV / sales at other companies

Abbott logo
AbbottABT
4.6×-1.0×
Boston Scientific logo
Boston ScientificBSX
-1.5×
Medtronic logo
MedtronicMDT
3.6×-0.4×
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
4.6×-0.2×
Merit Medical Systems logo
Merit Medical SystemsMMSI
2.9×-1.9×
Haemonetics logo
HaemoneticsHAE
2.7×-0.3×

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.32B+70.8%
Enterprise value$1.07B
P/S15.7×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Calculated from KMTS’s reported figures.

Based on the most recent quarter.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's EV / sales?
KMTS (KMTS) reported EV / sales of 14.2× in Q4 2025.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.